Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Cancer Biomarkers in Body Fluids - Gabriel D. Dakubo

Cancer Biomarkers in Body Fluids

Biomarkers in Circulation
Buch | Hardcover
XIX, 509 Seiten
2016 | 1st ed. 2017
Springer International Publishing (Verlag)
978-3-319-48359-7 (ISBN)
CHF 299,55 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This book examines in depth the evidence, clinical applications and potential cancer signatures in the circulation and discusses alterations in circulating cell-free nucleic acids, and circulating tumor DNA, as well as the epigenome, genome, transcriptome (coding and noncoding), proteome (both traditional serum proteins and proteomic profiles) and metabolome. Further, it highlights the clinical applications of circulating tumor cells for each cancer type and addresses the emerging importance of extracellular vesicular contents, including miRNA, oncogenes and drug resistant factors. As such, it offers a valuable reference guide for cancer researchers, oncologists, clinicians, surgeons, medical students, oncology nurses, diagnostic laboratories, and the pharmaceutical industry.

Dr. Gabriel D. Dakubo is an Assistant Professor of Molecular Medicine and Human Anatomy in the Division of Medical Sciences at the Northern Ontario School of Medicine. He received his BSc and MBChB degrees from the University of Ghana, followed by the pursuance of a Postdoctoral research fellowship in Molecular Medicine at the Ottawa Hospital Research Institute, Canada. Dr. Dakubo’s passion is in noninvasive deployment of biomarkers for cancer management. While an expert in mitochondrial genetic alterations in cancer, he also has a keen interest in the inter-genomic communications that occur in the cancer cell, as well as the Slaughter’s concept of field cancerization. Dr. Dakubo is well published, and is a reviewer of a number of esteemed journals, including Clinical Cancer Research.

1. Melanoma Biomarkers in Circulation. - 2. Head and Neck Cancer Biomarkers in Circulation. - 3. Lung Cancer Biomarkers in Circulation. - 4. Breast Cancer Biomarkers in Circulation. - 5. Esophageal Cancer Biomarkers in Circulation. - 6. Gastric Cancer Biomarkers in Circulation. - 7. Colorectal Cancer Biomarkers in Circulation. - 8. Hepatocellular Carcinoma Biomarkers in Circulation. - 9. Pancreatic Cancer Biomarkers in Circulation. - 10. Renal Cell Carcinoma Biomarkers in Circulation. - 11. Urothelial Bladder Cancer Biomarkers in Circulation. - 12. Prostate Cancer Biomarkers in Circulation. - 13. Ovarian Cancer Biomarkers in Circulation. - 14. Endometriosis Biomarkers in Body Fluids. - 15. Endometrial Cancer Biomarkers in Circulation. - 16. Cervical Cancer Biomarkers in Circulation. - 17. Endocrine Cancer Biomarkers in Circulation. - 18. Brain Tumor Biomarkers in Circulation.

Erscheinungsdatum
Zusatzinfo XIX, 509 p. 20 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 2. Studienabschnitt (Klinik) Humangenetik
Schlagworte Biomedical and Life Sciences • body fluid biomarkers • Cancer Management • Cancer Research • Human genetics • medical genetics • Medical Research • noninvasive diagnosis • Oncology • Protein targets • tissue-specific body fluids
ISBN-10 3-319-48359-5 / 3319483595
ISBN-13 978-3-319-48359-7 / 9783319483597
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller

von Siddhartha Mukherjee

Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
CHF 30,75
Die revolutionäre Medizin von morgen (Lifespan)

von David A. Sinclair; Matthew D. LaPlante

Buch | Softcover (2020)
DuMont Buchverlag
CHF 22,40